(Answered) NR601 Week 2: COPD Case Study Part 2

Total Points Possible:  50 

Case Study – Part 2

You ordered a CXR and spirometry at the previous visit and he returns today to review the results. Physical exam and symptoms are unchanged since last visit. Vital signs at this visit are: Temp-98.3, P-68, RR-20, BP 152/90, Height 68.9in., Weight 258 pounds, O2sat 94% on RA 

CXR Result: 

No acute infiltrates or consolidations are seen. Cardiac and mediastinal silhouettes are normal. No hilar enlargement is evident. Osseous thorax is intact. 

Spirometry Results: 

Pre-Bronchodilator  Post-Bronchodilator 
  Predicted  Actual  %Predicted  Actual  % Predicted  % Change 
FVC (L)  4.52  3.01  67  3.08  68  2 
FEV1 (L)  3.40  1.58  46  1.60  47  1 
FEV1/FV   .75  .52    .52    0 



  1. What is your primary (one) diagnosis for this patient at this time? (support the decision for your diagnosis with pertinent positives and negatives from the case)
  2. Identify the corresponding ICD-10 code.
  3. Provide a treatment plan for this patient’s primary diagnosis which includes:
    • Medication*
    • Any additional testing necessary for this particular diagnosis*
    • Patient education
    • Referral
    • Follow up
  4.  Provide an active problem list for this patient based on the information given in the case.
  5.  Are there any changes that you would also make to this patient’s overall treatment plan at this time? Must provide an EBP argument for each treatment or testing decision.

*If part of the plan does not warrant an action, you must explain why. ALL medication and testing decisions (or decisions not to treat with medication or additional testing) MUST be supported with an evidence-based practice  (EBP) argument. Over-the-counter (OTC) and RXs must be written in full as if handing a script to the patient in the office. 


Over-the-counter (OTC) and RXs must be written in full as if handing a prescription to the patient in the office.   


Amoxicillin 500 mg capsule  

1 tab po BID q 10 days  

Disp #20 no refills   



Primary diagnosis:  severe chronic obstructive pulmonary disease (COPD). Spirometry as demonstrated in the findings is required to make the diagnosis. The presence of post-bronchodilator FEV1/FVC < 0.70 confirms the presence of persistent airflow limitation hence the diagnosis of COPD (GOLD, 2019). This however should be supported by appropriate symptoms such as dyspnea and sputum, which are all present in the patient. The FEV1 values fall between 46% pre­­-bronchodilator and 47% post-bronchodilator, which support the criteria for severe COPD diagnosis (GOLD, 2019).

Corresponding ICD-10 code

ICD-10-CM J44.1


The pharmacological therapy for COPD .To access the solution  click the icon below to purchase at $10